Literature DB >> 25079767

Polyphenol isolated from Corni Fructus, 7-O-galloyl-D-sedoheptulose, modulates advanced glycation endproduct-related pathway in type 2 diabetic db/db mice.

Chan Hum Park1, Jeong Sook Noh, Takashi Tanaka, Seong-Soo Roh, Jang Cheon Lee, Takako Yokozawa.   

Abstract

7-O-Galloyl-D-sedoheptulose (GS) is the bioactive polyphenol isolated from the low-molecular-weight fraction of Corni Fructus (Cornus officinalis Sieb. et Zucc.). The present study was conducted to examine whether GS has an ameliorative effect on the liver of type 2 diabetic db/db mice. GS (20 or 100 mg/kg body weight/day, per os) was administered every day for 6 weeks to db/db mice, and its effect was compared with vehicle-treated db/db and m/m mice. The administration of GS decreased the elevated serum glucose, leptin, insulin, tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), resistin, and hepatic functional parameters, and reduced the increased fluorescent advanced glycation endproducts (AGEs) and reactive oxygen species in the liver. The db/db mice exhibited the up-regulation of receptor for AGEs (RAGE) and AGE-related proteins; however, GS treatment significantly reduced those expressions. Moreover, the augmented expressions of oxidative stress- and inflammation-related proteins, phospho-extracellular-signal regulated kinase 1/2, phospho-c-Jun N-terminal kinase, nuclear factor-kappa B, activator protein-1, monocyte chemotactic protein-1, intracellular adhesion molecule-1, TNF-α, and IL-6, were down-regulated by GS administration. Hematoxylin-eosin staining showed that the increased hepatocellular damage in the liver of db/db mice improved with GS administration. The present results support the evidence for GS ameliorating hepatic damage through the RAGE-mediated inflammation pathway.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25079767     DOI: 10.1007/s12272-014-0457-7

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  7 in total

1.  Zuogui Jiangtang Jieyu Formulation Prevents Hyperglycaemia and Depressive-Like Behaviour in Rats by Reducing the Glucocorticoid Level in Plasma and Hippocampus.

Authors:  YuHong Wang; Hui Yang; Wei Li; Pan Meng; YuanShan Han; Xiuli Zhang; DeLiang Cao; Yuansheng Tan
Journal:  Evid Based Complement Alternat Med       Date:  2015-07-27       Impact factor: 2.629

Review 2.  Corni Fructus: a review of chemical constituents and pharmacological activities.

Authors:  Yu Dong; Zhe-Ling Feng; Hu-Biao Chen; Fu-Sheng Wang; Jia-Hong Lu
Journal:  Chin Med       Date:  2018-06-25       Impact factor: 5.455

3.  Network Pharmacology-Based Identification of the Mechanisms of Shen-Qi Compound Formula in Treating Diabetes Mellitus.

Authors:  Zhipeng Hu; Maoyi Yang; Liangjun Yang; Chunguang Xie; Hong Gao; Xiaoxu Fu; Hongyan Xie; Ya Liu
Journal:  Evid Based Complement Alternat Med       Date:  2020-06-04       Impact factor: 2.629

Review 4.  Cornus mas and Cornus Officinalis-Analogies and Differences of Two Medicinal Plants Traditionally Used.

Authors:  Monika E Czerwińska; Matthias F Melzig
Journal:  Front Pharmacol       Date:  2018-08-28       Impact factor: 5.810

Review 5.  Active Components and Pharmacological Effects of Cornus officinalis: Literature Review.

Authors:  Xue Gao; Yi Liu; Zhichao An; Jian Ni
Journal:  Front Pharmacol       Date:  2021-04-12       Impact factor: 5.810

6.  Multiomics-based characterization of specialized metabolites biosynthesis in Cornus Officinalis.

Authors:  Amit Rai; Megha Rai; Hidetaka Kamochi; Tetsuya Mori; Ryo Nakabayashi; Michimi Nakamura; Hideyuki Suzuki; Kazuki Saito; Mami Yamazaki
Journal:  DNA Res       Date:  2020-04-01       Impact factor: 4.477

7.  The Herb Pair Radix Rehmanniae and Cornus Officinalis Attenuated Testicular Damage in Mice With Diabetes Mellitus Through Butyric Acid/Glucagon-Like Peptide-1/Glucagon-Like Peptide-1 Receptor Pathway Mediated by Gut Microbiota.

Authors:  Yuping Chen; Siyuan Song; Anmei Shu; Liping Liu; Jinjin Jiang; Ming Jiang; Qin Wu; Huiqin Xu; Jihu Sun
Journal:  Front Microbiol       Date:  2022-02-22       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.